These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16153690)
1. Amyloid peptide attenuates the proteasome activity in neuronal cells. Oh S; Hong HS; Hwang E; Sim HJ; Lee W; Shin SJ; Mook-Jung I Mech Ageing Dev; 2005 Dec; 126(12):1292-9. PubMed ID: 16153690 [TBL] [Abstract][Full Text] [Related]
2. Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes. Cecarini V; Bonfili L; Amici M; Angeletti M; Keller JN; Eleuteri AM Brain Res; 2008 May; 1209():8-18. PubMed ID: 18400214 [TBL] [Abstract][Full Text] [Related]
3. Intracellular Abeta and C99 aggregates induce mitochondria-dependent cell death in human neuroglioma H4 cells through recruitment of the 20S proteasome subunits. Park HJ; Kim SS; Kang S; Rhim H Brain Res; 2009 Jun; 1273():1-8. PubMed ID: 19362074 [TBL] [Abstract][Full Text] [Related]
4. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related]
5. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Gallardo G; Schlüter OM; Südhof TC Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066 [TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis. Salins P; He Y; Olson K; Glazner G; Kashour T; Amara F Neurosci Lett; 2008 Jan; 430(1):81-6. PubMed ID: 18063474 [TBL] [Abstract][Full Text] [Related]
7. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756 [TBL] [Abstract][Full Text] [Related]
8. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin. Fischer DF; van Dijk R; van Tijn P; Hobo B; Verhage MC; van der Schors RC; Li KW; van Minnen J; Hol EM; van Leeuwen FW Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506 [TBL] [Abstract][Full Text] [Related]
9. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
10. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126 [TBL] [Abstract][Full Text] [Related]
11. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Abdul HM; Calabrese V; Calvani M; Butterfield DA J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066 [TBL] [Abstract][Full Text] [Related]
12. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target. Bett JS; Goellner GM; Woodman B; Pratt G; Rechsteiner M; Bates GP Hum Mol Genet; 2006 Jan; 15(1):33-44. PubMed ID: 16311253 [TBL] [Abstract][Full Text] [Related]
13. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Petratos S; Li QX; George AJ; Hou X; Kerr ML; Unabia SE; Hatzinisiriou I; Maksel D; Aguilar MI; Small DH Brain; 2008 Jan; 131(Pt 1):90-108. PubMed ID: 18000012 [TBL] [Abstract][Full Text] [Related]
14. The ubiquitin-proteasome system in Creutzfeldt-Jakob and Alzheimer disease: intracellular redistribution of components correlates with neuronal vulnerability. Adori C; Kovács GG; Low P; Molnár K; Gorbea C; Fellinger E; Budka H; Mayer RJ; László L Neurobiol Dis; 2005 Aug; 19(3):427-35. PubMed ID: 16023585 [TBL] [Abstract][Full Text] [Related]
15. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau. Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643 [TBL] [Abstract][Full Text] [Related]
16. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation. Levi O; Dolev I; Belinson H; Michaelson DM J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042 [TBL] [Abstract][Full Text] [Related]
17. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Page G; Rioux Bilan A; Ingrand S; Lafay-Chebassier C; Pain S; Perault Pochat MC; Bouras C; Bayer T; Hugon J Neuroscience; 2006; 139(4):1343-54. PubMed ID: 16581193 [TBL] [Abstract][Full Text] [Related]
18. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579 [TBL] [Abstract][Full Text] [Related]
19. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene. Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423 [TBL] [Abstract][Full Text] [Related]
20. Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function. Rosen KM; Moussa CE; Lee HK; Kumar P; Kitada T; Qin G; Fu Q; Querfurth HW J Neurosci Res; 2010 Jan; 88(1):167-78. PubMed ID: 19610108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]